nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Thromboembolism—Prednisolone—psoriatic arthritis	0.0427	0.0427	CcSEcCtD
Gonadorelin—Thromboembolism—Triamcinolone—psoriatic arthritis	0.0392	0.0392	CcSEcCtD
Gonadorelin—Thromboembolism—Methylprednisolone—psoriatic arthritis	0.0391	0.0391	CcSEcCtD
Gonadorelin—Thromboembolism—Dexamethasone—psoriatic arthritis	0.0356	0.0356	CcSEcCtD
Gonadorelin—Thromboembolism—Betamethasone—psoriatic arthritis	0.0356	0.0356	CcSEcCtD
Gonadorelin—Thromboembolism—Prednisone—psoriatic arthritis	0.031	0.031	CcSEcCtD
Gonadorelin—Embolism venous—Prednisolone—psoriatic arthritis	0.0269	0.0269	CcSEcCtD
Gonadorelin—Embolism venous—Triamcinolone—psoriatic arthritis	0.0247	0.0247	CcSEcCtD
Gonadorelin—Embolism venous—Methylprednisolone—psoriatic arthritis	0.0247	0.0247	CcSEcCtD
Gonadorelin—Embolism venous—Dexamethasone—psoriatic arthritis	0.0224	0.0224	CcSEcCtD
Gonadorelin—Embolism venous—Betamethasone—psoriatic arthritis	0.0224	0.0224	CcSEcCtD
Gonadorelin—Embolism—Prednisolone—psoriatic arthritis	0.0211	0.0211	CcSEcCtD
Gonadorelin—Embolism venous—Prednisone—psoriatic arthritis	0.0195	0.0195	CcSEcCtD
Gonadorelin—Embolism—Triamcinolone—psoriatic arthritis	0.0194	0.0194	CcSEcCtD
Gonadorelin—Embolism—Methylprednisolone—psoriatic arthritis	0.0194	0.0194	CcSEcCtD
Gonadorelin—Flatulence—Auranofin—psoriatic arthritis	0.0183	0.0183	CcSEcCtD
Gonadorelin—Embolism—Dexamethasone—psoriatic arthritis	0.0176	0.0176	CcSEcCtD
Gonadorelin—Embolism—Betamethasone—psoriatic arthritis	0.0176	0.0176	CcSEcCtD
Gonadorelin—Embolism—Prednisone—psoriatic arthritis	0.0154	0.0154	CcSEcCtD
Gonadorelin—Dysmenorrhoea—Triamcinolone—psoriatic arthritis	0.0137	0.0137	CcSEcCtD
Gonadorelin—Constipation—Auranofin—psoriatic arthritis	0.013	0.013	CcSEcCtD
Gonadorelin—Contusion—Betamethasone—psoriatic arthritis	0.013	0.013	CcSEcCtD
Gonadorelin—Contusion—Dexamethasone—psoriatic arthritis	0.013	0.013	CcSEcCtD
Gonadorelin—Embolism—Methotrexate—psoriatic arthritis	0.0128	0.0128	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0124	0.0124	CcSEcCtD
Gonadorelin—Abdominal pain—Auranofin—psoriatic arthritis	0.012	0.012	CcSEcCtD
Gonadorelin—Contusion—Prednisone—psoriatic arthritis	0.0113	0.0113	CcSEcCtD
Gonadorelin—Pruritus—Auranofin—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Gonadorelin—Diarrhoea—Auranofin—psoriatic arthritis	0.0104	0.0104	CcSEcCtD
Gonadorelin—Vomiting—Auranofin—psoriatic arthritis	0.00965	0.00965	CcSEcCtD
Gonadorelin—Nausea—Auranofin—psoriatic arthritis	0.00902	0.00902	CcSEcCtD
Gonadorelin—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00816	0.00816	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00727	0.00727	CcSEcCtD
Gonadorelin—Erythema—Prednisolone—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Gonadorelin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00567	0.00567	CcSEcCtD
Gonadorelin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00565	0.00565	CcSEcCtD
Gonadorelin—Erythema—Triamcinolone—psoriatic arthritis	0.00545	0.00545	CcSEcCtD
Gonadorelin—Erythema—Methylprednisolone—psoriatic arthritis	0.00544	0.00544	CcSEcCtD
Gonadorelin—Breast disorder—Methotrexate—psoriatic arthritis	0.0054	0.0054	CcSEcCtD
Gonadorelin—Angiopathy—Dexamethasone—psoriatic arthritis	0.00516	0.00516	CcSEcCtD
Gonadorelin—Angiopathy—Betamethasone—psoriatic arthritis	0.00516	0.00516	CcSEcCtD
Gonadorelin—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Gonadorelin—Erythema—Dexamethasone—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Gonadorelin—Erythema—Betamethasone—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Gonadorelin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00484	0.00484	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.0048	0.0048	CcSEcCtD
Gonadorelin—Shock—Prednisolone—psoriatic arthritis	0.00476	0.00476	CcSEcCtD
Gonadorelin—Angiopathy—Prednisone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Gonadorelin—Immune system disorder—Prednisone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Gonadorelin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Gonadorelin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00444	0.00444	CcSEcCtD
Gonadorelin—Shock—Triamcinolone—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Gonadorelin—Shock—Methylprednisolone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Gonadorelin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Gonadorelin—Erythema—Prednisone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Gonadorelin—Pain—Prednisolone—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Gonadorelin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Gonadorelin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Gonadorelin—Shock—Dexamethasone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Gonadorelin—Shock—Betamethasone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Gonadorelin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Gonadorelin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Gonadorelin—Fatigue—Triamcinolone—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Gonadorelin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00383	0.00383	CcSEcCtD
Gonadorelin—Pain—Triamcinolone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Gonadorelin—Angiopathy—Methotrexate—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Gonadorelin—Immune system disorder—Methotrexate—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Gonadorelin—Erythema—Methotrexate—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Gonadorelin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Gonadorelin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Gonadorelin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Gonadorelin—Fatigue—Betamethasone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Gonadorelin—Fatigue—Dexamethasone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Gonadorelin—Shock—Prednisone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Gonadorelin—Pain—Betamethasone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Gonadorelin—Pain—Dexamethasone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Gonadorelin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.0033	0.0033	CcSEcCtD
Gonadorelin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Gonadorelin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Gonadorelin—Asthenia—Triamcinolone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Gonadorelin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Gonadorelin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Gonadorelin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Gonadorelin—Pruritus—Triamcinolone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Gonadorelin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Gonadorelin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Gonadorelin—Fatigue—Prednisone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Gonadorelin—Headache—Prednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Gonadorelin—Constipation—Prednisone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Gonadorelin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Gonadorelin—Asthenia—Dexamethasone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Gonadorelin—Asthenia—Betamethasone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Gonadorelin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Gonadorelin—Nausea—Prednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Gonadorelin—Pruritus—Betamethasone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Gonadorelin—Pruritus—Dexamethasone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Gonadorelin—Vomiting—Triamcinolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Gonadorelin—Vomiting—Methylprednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Gonadorelin—Headache—Triamcinolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Gonadorelin—Headache—Methylprednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Gonadorelin—Abdominal pain—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Gonadorelin—Diarrhoea—Betamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Gonadorelin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Gonadorelin—Nausea—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Gonadorelin—Nausea—Methylprednisolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Gonadorelin—Hypersensitivity—Prednisone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Gonadorelin—Vomiting—Dexamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Gonadorelin—Vomiting—Betamethasone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Gonadorelin—Fatigue—Methotrexate—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Gonadorelin—Headache—Betamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Gonadorelin—Headache—Dexamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Gonadorelin—Asthenia—Prednisone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Gonadorelin—Pain—Methotrexate—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Gonadorelin—Pruritus—Prednisone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Gonadorelin—Diarrhoea—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Gonadorelin—Nausea—Betamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Gonadorelin—Nausea—Dexamethasone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Gonadorelin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Gonadorelin—Vomiting—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Gonadorelin—Headache—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Gonadorelin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Gonadorelin—Asthenia—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Gonadorelin—Nausea—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Gonadorelin—Pruritus—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Gonadorelin—Diarrhoea—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Gonadorelin—Vomiting—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Gonadorelin—Headache—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Gonadorelin—Nausea—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
